Fundz

Watching BioClonetics Immunotherapeutics, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Bio Clonetics Immunotherapeutics, Inc. is looking to raise $200,000

Apr 11, 2017•over 9 years ago

Target Amount

$200,000

Deadline

Oct 08, 2017

CIK0001701251
File Number007-00033

Issuer ContactFrom SEC filing

Legal nameBioClonetics Immunotherapeutics, Inc.
Websitewww.bioclonetics.com
Address1756 Bison Meadow Lane
Heath, TX, 75032

Issuer Information

Issuer

BioClonetics Immunotherapeutics, Inc.

Location

1756 bison meadow lane

heath, ohio, united states

About

Creating fully human monoclonal antibodies that target and neutralize HIV and other infectious diseases.

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C)
Target Amount$200,000
Securities TypeOther
StateTX

Campaign Ended

Ended 3230 days ago

PlatformWefunder Portal LLC
View SEC Filing

Don't miss BioClonetics Immunotherapeutics, Inc.'s next move

Get an email the moment BioClonetics Immunotherapeutics, Inc. opens a raise, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.